5. Amgen

Total Ad Spend: $229.3 million
Television: $164 million
Magazine: $52.1 million
Other: $13.2 million

Amgen ($AMG) and Pfizer ($PFE), which shared marketing of the anti-inflammatory drug Enbrel in North America for years, dissolved their pact last year as Pfizer moved ahead with a competing treatment. Not about to let the top-selling drug lose momentum, Amgen pushed it in several different campaigns.

In the spotlight

Enbrel for arthritis, $127.1 million
Prolia, $60 million
Enbrel for psoriasis, $42.1 million



Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.